246 related articles for article (PubMed ID: 10373552)
21. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
22. Intertwining proteins in thymocyte development and cancer.
Murre C
Nat Immunol; 2000 Aug; 1(2):97-8. PubMed ID: 11248796
[No Abstract] [Full Text] [Related]
23. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
24. Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.
Qi Z; Sun XH
Mol Cell Biol; 2004 Sep; 24(17):7313-23. PubMed ID: 15314144
[TBL] [Abstract][Full Text] [Related]
25. Cre-loxP-mediated recombination between the SIL and SCL genes leads to a block in T-cell development at the CD4- CD8- to CD4+ CD8+ transition.
Cheng Y; Zhang Z; Slape C; Aplan PD
Neoplasia; 2007 Apr; 9(4):315-21. PubMed ID: 17460775
[TBL] [Abstract][Full Text] [Related]
26. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
[TBL] [Abstract][Full Text] [Related]
27. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
Baer R; Hwang LY; Bash RO
Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
[No Abstract] [Full Text] [Related]
28. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
29. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
30. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB.
Barndt RJ; Dai M; Zhuang Y
Mol Cell Biol; 2000 Sep; 20(18):6677-85. PubMed ID: 10958665
[TBL] [Abstract][Full Text] [Related]
31. Massive apoptosis of thymocytes in T-cell-deficient Id1 transgenic mice.
Kim D; Peng XC; Sun XH
Mol Cell Biol; 1999 Dec; 19(12):8240-53. PubMed ID: 10567549
[TBL] [Abstract][Full Text] [Related]
32. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
33. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
34. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
[TBL] [Abstract][Full Text] [Related]
35. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
36. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
37. E2A basic helix-loop-helix transcription factors in human leukemia.
LeBrun DP
Front Biosci; 2003 May; 8():s206-22. PubMed ID: 12700034
[TBL] [Abstract][Full Text] [Related]
38. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract][Full Text] [Related]
39. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.
Goardon N; Schuh A; Hajar I; Ma X; Jouault H; Dzierzak E; Roméo PH; Maouche-Chrétien L
Blood; 2002 Jul; 100(2):491-500. PubMed ID: 12091340
[TBL] [Abstract][Full Text] [Related]
40. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development.
Robb L; Begley CG
Int J Biochem Cell Biol; 1996 Jun; 28(6):609-18. PubMed ID: 8673726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
